Breast cancer screening coverage in Europe in Slovakia

Slovakia: Breast cancer screening coverage in Europe was 28.4% in 2022. ▼ Falling

Latest (2022)
28.4%
Change on year
up 11.7%
World rank
24th
of 26 countries
All-time high
34.9%
in 2009
All-time low
25.5%
in 2021
Years of data
17
2006–2022

Breast cancer screening coverage in Europe in Slovakia, 2006–2022

01020302006201420222006: 29.1 %2007: 32.4 %2008: 34.4 %2009: 34.9 %2010: 32.7 %2011: 31.1 %2012: 31.6 %2013: 30.5 %2014: 30.1 %2015: 30.4 %2016: 30.8 %2017: 30.7 %2018: 30.4 %2019: 31 %2020: 27.2 %2021: 25.5 %2022: 28.4 %

Source: Eurostat (2024) – processed by Our World in Data. Measured in %.

Analysis

In 2022, breast cancer screening coverage in europe in Slovakia stood at 28.4%.

Compared with earlier readings it is up 11.7% on the previous year and down 10.1% over ten years.

Over the whole period, breast cancer screening coverage in europe in Slovakia peaked at 34.9% in 2009 and was at its lowest, 25.5%, in 2021.

That places Slovakia 24th out of 26 countries with data for 2022, putting it in the bottom quarter.

The long-run direction has been consistently falling across the 17 years of available data.

Breast cancer screening coverage in Europe in Slovakia, year by year

Annual values for Breast cancer screening coverage in Europe in Slovakia, 2006 to 2022.
Year % Change
2006 29.1%
2007 32.4% +11.1%
2008 34.4% +6.2%
2009 34.9% +1.4%
2010 32.7% -6.3%
2011 31.1% -4.9%
2012 31.6% +1.9%
2013 30.5% -3.5%
2014 30.1% -1.6%
2015 30.4% +1.2%
2016 30.8% +1.2%
2017 30.7% -0.3%
2018 30.4% -0.8%
2019 31.0% +1.7%
2020 27.2% -12.1%
2021 25.5% -6.5%
2022 28.4% +11.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 32.7% 29.1% 34.9% 4
2010s 30.9% 30.1% 32.7% 10
2020s 27.0% 25.5% 28.4% 3

Countries ranked near Slovakia

  1. 21 Latvia 30.2% compare
  2. 22 Hungary 29.8% compare
  3. 23 Cyprus 29.3% compare
  4. 25 Liechtenstein 11.9% compare
  5. 26 Serbia 6.1% compare

See the full ranking of 26 places →

More health data for Slovakia

All data for Slovakia →

Frequently asked questions

What is breast cancer screening coverage in europe in Slovakia?
Breast cancer screening coverage in europe in Slovakia was 28.4% in 2022, according to Eurostat (2024) – processed by Our World in Data.
What is the highest breast cancer screening coverage in europe recorded in Slovakia?
The highest recorded value was 34.9% in 2009.
What is the lowest breast cancer screening coverage in europe recorded in Slovakia?
The lowest recorded value was 25.5% in 2021.
How does Slovakia rank for breast cancer screening coverage in europe?
Slovakia ranks 24th out of 26 countries with data for 2022.
Is breast cancer screening coverage in europe rising or falling in Slovakia?
Over the last ten years it is down 10.1%. The long-run trend across the full record is falling.
Where does this Slovakia data come from?
The figures come from Eurostat (2024) – processed by Our World in Data, published as part of Breast cancer screening coverage in Europe. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Breast cancer screening coverage in Europe in Slovakia. Statizoid, drawing on Eurostat (2024) – processed by Our World in Data. Retrieved 29 August 2026, from https://health.statizoid.com/stat/breast-cancer-screening-coverage-in-europe/slovak-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/breast-cancer-screening-coverage-in-europe/slovak-republic/">Breast cancer screening coverage in Europe in Slovakia</a> — Statizoid

About this data

Indicator
Breast cancer screening coverage in Europe
Unit
%
Source
Eurostat (2024) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
26 places, 424 data points, 2000–2022
Last refreshed

Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.